Skip to main content
OpenTrials

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,764 public trials 2,078 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma trial results

Active, Not Recruiting

Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform (ELEPHAS-02)

NCT05520099

Conditions
Adenocarcinoma, Bladder Cancer, Bronchial Neoplasms, +72 more
Locations
  • CARTI Cancer Center Little Rock, Arkansas, United States
  • Salinas Valley Memorial Healthcare System Salinas, California, United States
  • AdventHealth Orlando Orlando, Florida, United States
  • Memorial Health System Pembroke Pines, Florida, United States
View Trial Details
Active, Not Recruiting

RRx-001 for Reducing Oral Mucositis in Patients Receiving Chemotherapy and Radiation for Head and Neck Cancer

NCT05966194

Conditions
Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +14 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • Miami Cancer Institute Miami, Florida, United States
  • Northwestern University Feinberg School of Medicine Chicago, Illinois, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors

NCT05277051

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +49 more
Locations
  • GSK Investigational Site San Francisco, California, United States
  • GSK Investigational Site Charlotte, North Carolina, United States
  • GSK Investigational Site Oklahoma City, Oklahoma, United States
  • GSK Investigational Site Philadelphia, Pennsylvania, United States
View all 26 locations
View Trial Details
Active, Not Recruiting

First Line Treatment With Olaparib in Combination With Bevacizumab in HRD Positive Patients

NCT06121401

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +16 more
Locations
  • Azienda Socio Sanitaria Territoriale (ASST) Lariana San Fermo della Battaglia, Como, Italy
  • Spedali Civili Brescia, Italy
  • Policlinico Careggi Florence, Italy
  • Ospedale Manzoni Lecco, Italy
View all 14 locations
View Trial Details
Active, Not Recruiting

IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE Cancers

NCT06790706

Conditions
Adenocarcinoma, Anaplastic Thyroid Carcinomas, Carcinoid Tumor, +27 more
Locations
  • Institut de Cancerologie de l'Ouest , medical oncology department Angers, France
  • Institut Bergonié, medical oncology department Bordeaux, France
  • Hospices Civils de Lyon, Thoracic Oncology Department, Louis Pradel Hospital Bron, France
  • Centre Hospitalier Universitaire de Lille, medical oncology department Lille, France
View all 15 locations
View Trial Details
Active, Not Recruiting

Individualized Treatment Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA

NCT02135042

Conditions
Carcinoma, DNA Virus Infections, Epstein-Barr Virus Infection, +22 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • The Kirklin Clinic at Acton Road Birmingham, Alabama, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • Sutter Cancer Centers Radiation Oncology Services-Auburn Auburn, California, United States
View all 215 locations
View Trial Details

Related conditions